454 results found
Mason Hayes & Curran LLP | Ireland, United Kingdom | 1 Sep 2023
Navigating Forms of Cross-Undertaking Applications
The Irish High Court granted an injunction in February 2023 in favour of Bristol-Myers Squibb (BMS), a global biopharmaceutical company, against Teva…
Pinsent Masons | United Kingdom | 23 Jan 2023
Siemens v GE: out of sight, out of scope?
Given the current energy crisis and pressing need for alternative energy solutions, patent disputes in the energy sector will undoubtedly increase. In one recent dispute in this space, the High Court invalidated one of Siemens Gamesa's patents in relation to offshore wind turbines. This article addresses claim construction, the relevance of the prosecution history and territorial limits to......
Lexology PRO | United Kingdom | 23 Nov 2022
Pharma executives flouted compliance rules when striking supply agreement, CMA claims
An in-house lawyer at a drugmaker since bought out by Advanz Pharma allowed the company’s most senior staff to hold meetings without strictly abiding by certain compliance rules, counsel to the UK's Competition and Markets Authority has claimed.
Lexology PRO | European Union, Italy, Netherlands, etc. | 19 Jul 2021
Dutch enforcer issues first excessive pricing fine
The Dutch competition authority has fined Leadiant Biosciences €17.9 million for charging excessively high prices for a drug used to treat a rare genetic metabolic disorder, marking the first time it has ever imposed a penalty for such an infringement.
Lexology PRO | United Kingdom | 15 Jul 2021
UK hits pharma companies with £266 million fines for overcharging health service
The UK’s Competition and Markets Authority has fined four drugmakers over £266 million for inflating the price of a life-saving drug by over 10,000% and preventing the entry of competing medicines.
PRO Compliance | USA | 11 Jun 2020
States file third suit against generics industry
A coalition of 51 US states and territories have filed their third sweeping antitrust lawsuit against the generic pharmaceuticals industry, alleging a massive conspiracy to fix prices for topical skin treatments.
AA Thornton IP LLP | United Kingdom | 20 Nov 2018
Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (Pregabalin/Lyrica)
The Supreme Court of the United Kingdom has now released their long-awaited decision relating to the tests for sufficiency and infringement for second…
Freshfields Bruckhaus Deringer | European Union, United Kingdom | 14 Nov 2018
UK Supreme Court patent decision in Lyrica: What you need to know
The UK Supreme Court handed down its much anticipated judgment in the Warner-Lambert v Mylan and Actavis (Lyrica) case today (https://www…
Knobbe Martens | USA | 11 Sep 2018
Orexo AB, Orexo US INC., v Actavis Elizabeth LLC
Objective indicia of nonobviousness cannot be dismissed merely because all the ingredients in a formulation were generally known and nothing prevented…
Rothwell, Figg, Ernst & Manbeck, PC | USA | 7 Aug 2018
Using Theses as Prior Art at the PTAB
Based on recent Patent Trial and Appeal Board (“PTAB” or “the Board”) decisions, the best practice to establish an academic thesis as a printed…
